[Ptosis and ophthalmoplegia as predominant signs of multiple myeloma].
D001763:Blepharoptosis / Q000209:etiology*; D017024:Chemotherapy, Adjuvant; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D009886:Ophthalmoplegia / Q000209:etiology*; D010255:Paranasal Sinus Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D010954:Plasmacytoma / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D012888:Skull Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D013101:Sphenoid Sinus / Q000473:pathology; D013249:Sternum / Q000473:pathology / Q000601:surgery; D013899:Thoracic Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D020333:Tolosa-Hunt Syndrome / Q000209:etiology; D016896:Treatment Outcome
Ptosis und Ophthalmoplegie als Leitsymptome eines multiplen Myeloms.